President's Malaria Initiative
U.S. government initiative to combat malaria
The President's Malaria Initiative (PMI) is a United States government initiative aimed at reducing the burden of malaria and decreasing malaria-related mortality in sub-Saharan Africa and other regions affected by the disease. Launched in 2005, PMI is a collaborative effort led by the United States Agency for International Development (USAID) and implemented in partnership with the Centers for Disease Control and Prevention (CDC).
History
The President's Malaria Initiative was announced by President George W. Bush in 2005 as a five-year, $1.2 billion program to reduce malaria deaths by 50% in 15 African countries. The initiative was part of a broader effort to address global health challenges and was initially focused on high-burden countries in sub-Saharan Africa.
Objectives
PMI aims to reduce malaria-related mortality through a comprehensive approach that includes prevention, treatment, and control strategies. The initiative focuses on scaling up proven interventions such as the distribution of insecticide-treated nets (ITNs), indoor residual spraying (IRS), prompt and effective treatment with artemisinin-based combination therapies (ACTs), and intermittent preventive treatment in pregnancy (IPTp).
Implementation Strategies
PMI works in close collaboration with national malaria control programs, international organizations, and local partners to implement its strategies. The initiative emphasizes capacity building, strengthening health systems, and promoting sustainable practices to ensure long-term impact.
Prevention
Prevention efforts under PMI include the widespread distribution of insecticide-treated nets and the implementation of indoor residual spraying campaigns. These interventions are designed to reduce the transmission of malaria by targeting the Anopheles mosquitoes that spread the disease.
Treatment
PMI supports the provision of effective malaria treatment through the distribution of artemisinin-based combination therapies. The initiative also works to improve diagnostic capabilities by supporting the use of rapid diagnostic tests (RDTs) to ensure accurate and timely diagnosis of malaria cases.
Capacity Building
A key component of PMI is the strengthening of local health systems and capacity building. This includes training healthcare workers, improving supply chain management, and enhancing data collection and analysis to inform decision-making and policy development.
Impact
Since its inception, PMI has contributed to significant reductions in malaria-related mortality and morbidity in partner countries. The initiative has played a crucial role in scaling up malaria control interventions and has been instrumental in the global effort to combat malaria.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD